![Interplay between inflammation and thrombosis in cardiovascular pathology | Nature Reviews Cardiology Interplay between inflammation and thrombosis in cardiovascular pathology | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-021-00552-1/MediaObjects/41569_2021_552_Fig1_HTML.png)
Interplay between inflammation and thrombosis in cardiovascular pathology | Nature Reviews Cardiology
![Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation | Hypertension Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation | Hypertension](https://www.ahajournals.org/cms/asset/a7cb5f55-76f0-418d-b088-45d25d2f35e5/hypertensionaha.121.16975.fig03.jpg)
Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation | Hypertension
Journal of Clinical Investigation - In JCI Insight: Isoquercetin reduces coagulation markers in patients at risk of thrombosis https://buff.ly/2EnvDPu The release of protein disulfide isomerase (PDI) from cells during disease or in
![Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case–control study | Eye Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case–control study | Eye](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Feye.2010.8/MediaObjects/41433_2010_Article_BFeye20108_Figa_HTML.jpg)
Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case–control study | Eye
![Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease - LOWE - 2005 - Journal of Thrombosis and Haemostasis - Wiley Online Library Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease - LOWE - 2005 - Journal of Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/09717426-1625-403a-adca-b95377dba46f/jth_1416_f1.gif)
Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease - LOWE - 2005 - Journal of Thrombosis and Haemostasis - Wiley Online Library
![D-dimer levels as marker of deep vein thrombosis in patients with cervical cancer: A study of a northern Nigerian patient population | Semantic Scholar D-dimer levels as marker of deep vein thrombosis in patients with cervical cancer: A study of a northern Nigerian patient population | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c742824399d7755c16fff5891c0172368855f006/3-Table1-1.png)
D-dimer levels as marker of deep vein thrombosis in patients with cervical cancer: A study of a northern Nigerian patient population | Semantic Scholar
![Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-021-00665-7/MediaObjects/41569_2021_665_Fig1_HTML.png)
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium | Nature Reviews Cardiology
![IJMS | Free Full-Text | Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis IJMS | Free Full-Text | Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis](https://pub.mdpi-res.com/ijms/ijms-22-05967/article_deploy/html/images/ijms-22-05967-g001.png?1622707405)
IJMS | Free Full-Text | Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis
![Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism - BETACH3 Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism - BETACH3](https://betach3.com/wp-content/uploads/2020/12/FireShot-Capture-018-Frontiers-Prognostic-Genetic-Markers-for-Thrombosis-in-COVID-19-Pat_-www.frontiersin.org_.png)
Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism - BETACH3
![Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets | Physiological Reviews Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets | Physiological Reviews](https://journals.physiology.org/cms/10.1152/physrev.00035.2020/asset/images/medium/prv-00035-2020r01.png)